- CEO
- Myung-Jae Lee
- Full Time Employees
- 158
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Address
- Gunpo-si South Korea
- IPO Date
- Dec 11, 2020
- Business
- ENBIO Co., Ltd. is a South Korea-based agricultural chemical and biotechnology company primarily engaged in the research, development, manufacturing, and distribution of crop protection products and specialized agricultural materials. Founded in 1997 and headquartered in Gunpo-si, Gyeonggi-do, South Korea, the company develops eco-friendly and synthetic chemical formulations designed to protect crop yields and manage plant pathogens, pest infestations, and weed competition across diverse agricultural environments.
The company categorizes its primary operations into several core product segments: fungicides, including proprietary formulations such as Garujabi, Golden Balance, Gyunstyle, Napoleon, Barosen, Rotiple, and Rommel, designed to control crop diseases such as anthracnose and powdery mildew; insecticides, comprising products such as Gangcheolbi, Gongseup, Ggakjiside, Nabang Plus, Dongjakgeuman, New Jeungwongun, Daytona, Manneungkey, and Mobenking for pest and vector control; herbicides, including selective and non-selective weed control agents such as Gangchota, Golden Age, Nonaeda, Nonejoa, Deopuresen, Debunol, Mantis, Blackout, Salcho-N, and Inbio Bentazone; eco-friendly crop protection agents and biopesticides, centered on proprietary lime-sulfur compound technologies and organic disease control solutions; and plant growth regulators alongside micronutrient compound fertilizers engineered to enhance crop vitality and soil productivity.
ENBIO supplies its products across South Korea through primary agricultural distribution networks, including NongHyup Economic Holdings, regional unit agricultural cooperatives, and independent wholesale and retail dealers. Internationally, the company maintains active export channels to markets across Asia and Central Asia, including Uzbekistan, China, and Pakistan.
In recent operational and strategic developments, ENBIO has advanced the commercialization of its proprietary novel fungicide compounds developed in collaboration with national research initiatives backed by the South Korean Ministry of Trade, Industry and Energy, targeting international licensing and commercial distribution. The company has substantially expanded its sales penetration through the domestic NongHyup cooperative network, contributing to double-digit revenue expansion driven by herbicide and fungicide export volumes. Additionally, ENBIO implemented key governance and executive changes, including the appointment of Lee Hyeok-jae as Chief Executive Officer in mid-2026 and the institutional restructuring of internal compliance and financial disclosure control systems to support ongoing corporate expansion.